Gastric Stump Cancer After Distal Gastrectomy for Benign Disease: Clinicopathological Features and Surgical Outcomes

2014 ◽  
Vol 21 (8) ◽  
pp. 2594-2600 ◽  
Author(s):  
Alberto Di Leo ◽  
Corrado Pedrazzani ◽  
Maria Bencivenga ◽  
Arianna Coniglio ◽  
Fausto Rosa ◽  
...  
2021 ◽  
Vol 102 (1) ◽  
pp. 100-103
Author(s):  
F Sh Akhmetzyanov ◽  
N A Valiev ◽  
V I Egorov ◽  
M I Shaymardanov

Gastric stump cancer is a carcinoma which forms no earlier than 5years after surgery for benign disease. The incidence ranges from 2.4 to 5% among patients with stomach cancer. Previous operations lead to the emergence of an adhesive process in the abdominal cavity, changes in the anatomy and topography of the abdominal organs, as well as the development of new ways of lymph outflow. These factors lead to the re-surgery becomes technically more complicated and requires high professional training from the surgeon. Of particular surgical interest is the issue of restoration of the digestive tract, which directly depends on the nature and volume of the previous surgery. In this paper, the authors describe cases of surgical treatment of gastric stump cancer in two patients, who had previously undergone pancreaticoduodenectomy.


2008 ◽  
Vol 15 (6) ◽  
pp. 1632-1639 ◽  
Author(s):  
Hye Seong Ahn ◽  
Jong Won Kim ◽  
Moon-Won Yoo ◽  
Do Joong Park ◽  
Hyuk-Joon Lee ◽  
...  

2015 ◽  
Vol 5 (3) ◽  
pp. 104-106
Author(s):  
Ferdane Sapmaz ◽  
Sebahat Basyigit ◽  
Metin Uzman ◽  
Gulcin Guler Simsek ◽  
Tolga Akkan ◽  
...  

A 60 year old man was referred to our hospital with the chief complaints of abdominal pain and vomiting. He underwent a distal gastrectomy with a Billroth II gastrojejunostomy for a peptic ulcer 13 years ago. Esophagogastroduodenoscopy (EGD) did not reveal any gross lesion in the stomach but depigmented areas were seen in the anastomosis line. The histopathology of the anastomotic area revealed poorly differentiated adenocarcinoma. Gastric stump cancers can be polypoid, fungating, ulcerated and diffusely infiltrating tumors respectively. In our case, the appearance of adenocarcinoma was quite different from that described in the classification system.


The Lancet ◽  
1994 ◽  
Vol 343 (8889) ◽  
pp. 66-67 ◽  
Author(s):  
G.J.A. Offerhaus

2009 ◽  
Vol 9 (Suppl 1) ◽  
pp. A84
Author(s):  
Bledar Koltraka ◽  
Eriberto Farinella ◽  
Ivan Barillaro ◽  
Roberto Cirocchi ◽  
Alban Cacurri ◽  
...  

Author(s):  
Makoto Hikage ◽  
Masanori Tokunaga ◽  
Rie Makuuchi ◽  
Yutaka Tanizawa ◽  
Etsuro Bando ◽  
...  

Objective Robot-assisted gastrectomy is increasingly used for the treatment of gastric cancer, although it remains a time-consuming procedure. An ultrasonically activated device might be useful to shorten operation times. This study therefore assessed the effect of ultrasonically activated device use on procedural times and on other early surgical outcomes. Methods Consecutive patients (N = 42) who underwent robot-assisted distal gastrectomy for gastric cancer were included. Clinicopathological characteristics and early surgical outcomes were compared between robotic-assisted gastrectomy procedures using an ultrasonically activated device (U group, n = 21) and those without it (NU group, n = 21). Results There were no significant differences in patient characteristics between the groups; however, the median operation time was significantly less in the U group than in the NU group (291 vs 351 minutes, P = 0.006). In detail, the median duration of console time until dividing the duodenum was less in the U group (70 vs 102 minutes, P < 0.001). Estimated blood loss, incidence of postoperative morbidity, and duration of postoperative hospital stay were not different between the groups. Conclusions An ultrasonically activated device reduced the operation time of robot-assisted gastrectomy without increasing blood loss and morbidity.


Sign in / Sign up

Export Citation Format

Share Document